Preweaning modulation of intestinal microbiota by oligosaccharides or amoxicillin can contribute to programming of adult microbiota in rats

Nutrition

Volumn 31, Issue 3, 2015, Pages 515-522

  Morel, Fanny B ^a,b,c,d   Oozeer, Raish ^c   Piloquet, Hugues ^a,b,d,e,f   Moyon, Thomas ^a,b,d,e   Pagniez, Anthony ^a,b,d,e   Knol, Jan ^c   Darmaun, Dominique ^a,b,d,e,f   Michel, Catherine ^a,b,d,e  

^a Universite de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Nutricia Nederland   (Netherlands)

^d CRNH AUVERGNE   (France)

^e IMAD   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic; Early nutrition; Intestinal microbiota; Prebiotic; Programming

Indexed keywords

AMOXICILLIN; FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; OLIGOSACCHARIDE; ANTIINFECTIVE AGENT; PREBIOTIC AGENT;

ALLOBACULUM; ANIMAL EXPERIMENT; ARTICLE; BACTEROIDES; BIFIDOBACTERIUM; BUTYRASE KINASE GENE; CATENIBACTERIUM; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; COLON FLORA; CONTROLLED STUDY; COPROCOCCUS; DIET SUPPLEMENTATION; ERYSIPELOTRICHACEAE; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; FEMALE; FIRMICUTES; GENE; INTESTINE FLORA; LACTOBACILLALES; MALE; METHANOBACTERIALES; NONHUMAN; OSCILLIBACTER; PREVOTELLA; RAT; ROSEBURIA INTESTINALIS; SHIGELLA; SUCKLING ANIMAL; WEANING; ANIMAL; BACTERIUM; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LARGE INTESTINE; MICROBIOLOGY; SPRAGUE DAWLEY RAT;

ERYSIPELOTRICHACEAE; FIRMICUTES; RATTUS; ROSEBURIA INTESTINALIS;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; FRUCTANS; GASTROINTESTINAL MICROBIOME; INTESTINE, LARGE; MALE; OLIGOSACCHARIDES; PREBIOTICS; RATS, SPRAGUE-DAWLEY; WEANING;

EID: 84923064444     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.09.011     Document Type: Article

References (70)

1. Lucas A. Role of nutritional programming in determining adult morbidity. Arch Dis Child 1994, 71:288-290.
2. Symonds M.E., Gardner D.S. Experimental evidence for early nutritional programming of later health in animals. Curr Opin Clin Nutr Metab Care 2006, 9:278-283.
3. Zeisel S.H. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr 2009, 89:1488S-1493S.
4. Mischke M., Plosch T. More than just a gut instinct-the potential interplay between a baby's nutrition, its gut microbiome, and the epigenome. Am J Physiol Regul Integr Comp Physiol 2013, 304:R1065-R1069.
5. Haemer M.A., Huang T.T., Daniels S.R. The effect of neurohormonal factors, epigenetic factors, and gut microbiota on risk of obesity. Prev Chronic Dis 2009, 6:A96.
6. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
7. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
8. Musso G., Gambino R., Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 2010, 33:2277-2284.
9. Collins S.M., Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136:2003-2014.
10. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3:213-223.
11. Samuel B.S., Gordon J.I. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 2006, 103:10011-10016.
12. Adlerberth I., Wold A.E. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009, 98:229-238.
13. Rinne M., Kalliomaki M., Salminen S., Isolauri E. Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. J Pediatr Gastroenterol Nutr 2006, 43:200-205.
14. Magne F., Hachelaf W., Suau A., Boudraa G., Bouziane-Nedjadi K., Rigottier-Gois L., et al. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. J Pediatr Gastroenterol Nutr 2008, 46:580-588.
15. Spor A., Koren O., Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011, 9:279-290.
16. Mackie R.I., Sghir A., Gaskins H.R. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999, 69:1035S-1045S.
17. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
18. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
19. Relman D.A. The human microbiome: ecosystem resilience and health. Nutr Rev 2012, 70(Suppl 1):S2-S9.
20. Midtvedt A.C., Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 y of human life. J Pediatr Gastroenterol Nutr 1992, 15:395-403.
21. Salvini F., Riva E., Salvatici E., Boehm G., Jelinek J., Banderali G., et al. A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects. J Nutr 2011, 141:1335-1339.
22. Gronlund M.M., Lehtonen O.P., Eerola E., Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999, 28:19-25.
23. Salminen S., Gibson G.R., McCartney A.L., Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut 2004, 53:1388-1389.
24. Fujiwara R., Takemura N., Watanabe J., Sonoyama K. Maternal consumption of fructo-oligosaccharide diminishes the severity of skin inflammation in offspring of NC/Nga mice. Br J Nutr 2010, 103:530-538.
25. Ellis-Pegler R.B., Crabtree C., Lambert H.P. The faecal flora of children in the United Kingdom. J Hyg 1975, 75:135-142.
26. Tannock G.W. What immunologists should know about bacterial communities of the human bowel. Semin Immunol 2007, 19:94-105.
27. Inoue R., Ushida K. Development of the intestinal microbiota in rats and its possible interactions with the evolution of the luminal IgA in the intestine. FEMS Microbiol Ecol 2003, 45:147-153.
28. Fanca-Berthon P., Hoebler C., Mouzet E., David A., Michel C. Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats. J Pediatr Gastroenterol Nutr 2010, 51:402-413.
29. Marra F., Marra C.A., Richardson K., Lynd L.D., Kozyrskyj A., Patrick D.M., et al. Antibiotic use in children is associated with increased risk of asthma. Pediatrics 2009, 123:1003-1010.
30. Schmitt J., Schmitt N.M., Kirch W., Meurer M. Early exposure to antibiotics and infections and the incidence of atopic eczema: a population-based cohort study. Pediatr Allergy Immunol 2010, 21:292-300.
31. Braegger C., Chmielewska A., Decsi T., Kolacek S., Mihatsch W., Moreno L., et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011, 52:238-250.
32. Rastall R.A. Functional oligosaccharides: application and manufacture. Annu Rev Food Sci Technol 2010, 1:305-339.
33. Arboleya S., Ang L., Margolles A., Yiyuan L., Dongya Z., Liang X., et al. Deep 16 S rRNA metagenomics and quantitative PCR analyses of the premature infant fecal microbiota. Anaerobe 2012, 18:378-380.
34. Nadkarni M.A., Martin F.E., Jacques N.A., Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002, 148:257-266.
35. Watanabe K., Kodama Y., Harayama S. Design and evaluation of PCR primers to amplify bacterial 16 S ribosomal DNA fragments used for community fingerprinting. J Microbiol Methods 2001, 44:253-262.
36. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16 S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166-1177.
37. Vanhoutte T., De Preter V., De Brandt E., Verbeke K., Swings J., Huys G. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol 2006, 72:5990-5997.
38. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., et al. Quantitative PCR with 16 S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 2004, 70:167-173.
39. Layton A., McKay L., Williams D., Garrett V., Gentry R., Sayler G. Development of Bacteroides 16 S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl Environ Microbiol 2006, 72:4214-4224.
40. Penders J., Vink C., Driessen C., London N., Thijs C., Stobberingh E.E. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol Lett 2005, 243:141-147.
41. Heilig H.E., Zoetendal E., Vaughan M.P., Akkermans A.D., de Vos W.M. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16 S ribosomal DNA. Appl Environ Microbiol 2002, 68:114-123.
42. Wang R.F., Cao W.W., Cerniglia C.E. PCR detection and quantitation of predominant anaerobic bacteria in human and animal fecal samples. Appl Environ Microbiol 1996, 62:1242-1247.
43. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009, 101:541-550.
44. Stahl D.A., Amman R. Development and application of nucleic acid probes. Nuleic acid techniques in bacterial systematics 1991, 205-248. John Wiley & Sons Ltd, Chichester (GBR). E. Stackebrandt, M. Goodfellow (Eds.).
45. Raskin L., Stromley J.M., Rittmann B.E., Stahl D.A. Group-specific 16 S rRNA hybridization probes to describe natural communities of methanogens. Appl Environ Microbiol 1994, 60:1232-1240.
46. Walker A.W., Ince J., Duncan S.H., Webster L.M., Holtrop G., Ze X., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011, 5:220-230.
47. Louis P., Duncan S.H., McCrae S.I., Millar J., Jackson M.S., Flint H.J. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol 2004, 186:2099-2106.
48. Louis P., Flint H.J. Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol 2007, 73:2009-2012.
49. Zhang X., Zhao Y., Zhang M., Pang X., Xu J., Kang C., et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 2012, 7:e42529.
50. R Development Core Team R: a language and environment for statistical computing 2011, R Foundation for Statistical Computing, Available at:, Accessed October 23, 2014. http://www.R-project.org/.
51. Schumann A., Nutten S., Donnicola D., Comelli E.M., Mansourian R., Cherbut C., et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005, 23:235-245.
52. Montesi A., Garcia-Albiach R., Pozuelo M.J., Pintado C., Goñi I., Rotger R. Molecular and microbiologic analysis of caecal microbiota in rats fed withdiets supplemented either with prebiotics or probiotics. Int J Food Microbiol 2005, 98:281-289.
53. Fanaro S., Jelinek J., Stahl B., Boehm G., Kock R., Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr 2005, 41:186-190.
54. Vos A.P., Haarman M., van Ginkel J.W., Knol J., Garssen J., Stahl B., et al. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr Allergy Immunol 2007, 18:304-312.
55. Rao S., Srinivasjois R., Patole S. Prebiotic supplementation in full-term neonates: A systematic review of randomized controlled trials. Arch Pediatr Adolesc Med 2009, 163:755-764.
56. Davis L.M., Martínez I., Walter J., Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int J Food Microbiol 2010, 144:285-292.
57. de Preter V., Vanhoutte T., Huys G., Swings J., Rutgeerts P., Verbeke K. Baseline microbiota activity and initial bifidobacteria counts influence responses toprebiotic dosing in healthy subjects. Aliment Pharmacol Ther 2008, 27:504-513.
58. Dewulf E.M., Cani P.D., Neyrinck A.M., Possemiers S., Van Holle A., Muccioli G.G., et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem 2011, 22:712-722.
59. Shen J., Zhang B., Wei H., Che C., Ding D., Hua X., et al. Assessment of the modulating effects of fructo-oligosaccharides on fecal microbiota using human flora-associated piglets. Arch Microbiol 2010, 192:959-968.
60. Reid G., Younes J.A., Van der Mei H.C., Gloor G.B., Knight R., Busscher H.J. Microbiota restoration: Natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011, 9:27-38.
61. Benson A.K., Kelly S.A., Legge R., Ma F., Low S.J., Kim J., et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A 2010, 107:18933-18938.
62. Koenig J.E., Spor A., Scalfone N., Fricker A.D., Stombaugh J., Knight R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011, 108(Suppl 1):4578-4585.
63. van Hoffen E., Ruiter B., Faber J., M'Rabet L., Knol E.F., Stahl B., et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009, 64:484-487.
64. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27:104-119.
65. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 2009, 106:2365-2370.
66. Spencer M.D., Hamp T.J., Reid R.W., Fischer L.M., Zeisel S.H., Fodor A.A. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011, 140:976-986.
67. Zhu Q., Jin Z., Wu W., Gao R., Guo B., Gao Z., et al. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One 2014, 9:e90849.
68. Willing B.P., Dicksved J., Halfvarson J., Andersson A.F., Lucio M., Zheng Z., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139:1844-1854.e1.
69. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012, 6:320-329.
70. Neyrinck A.M., Possemiers S., Verstraete W., De Backer F., Cani P.D., Delzenne N.M. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem 2012, 23:51-59.